Selling dietary supplements in the United States requires compliance with FDA regulations. Understanding the registration process, facility requirements, and labeling rules is essential for legal market entry.
Important: This guide provides general information. Consult with a regulatory expert for specific compliance advice.
All facilities that manufacture, pack, or hold dietary supplements for sale in the US must register with the FDA.
Current Good Manufacturing Practice (cGMP) regulations are required for dietary supplement manufacturers.
Verify identity of dietary ingredients through at least one appropriate test.
Test for contaminants including heavy metals, pesticides, and microbes.
Verify that products meet their labeled specifications.
Ensure product composition matches batch records and specifications.
Dietary supplement labels must include specific information:
Note: New dietary ingredients (NDI) not marketed in the US before October 15, 1994 require premarket notification to the FDA with evidence of reasonable expectation of safety.
The Dietary Supplement Health and Education Act (DSHEA) of 1994 established the regulatory framework for dietary supplements. Key points include:
FDA conducts inspections of dietary supplement facilities to ensure compliance with cGMP regulations. Inspections may be:
Non-compliance can result in warning letters, product recalls, import alerts, and in severe cases, criminal prosecution.